Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Nose and Nasal Cavity01:24

Nose and Nasal Cavity

3.6K
The nose is composed of an observable exterior segment (external nose) and an internal segment within the skull known as the nasal cavity (internal nose). The external nose, visible on the face, consists of a framework of bone and hyaline cartilage enveloped in skin and muscle and lined with a mucous membrane. This structure is supported by the frontal bone, nasal bones, and maxillary bone and is supplemented by a cartilaginous framework comprising the septal nasal cartilage, lateral nasal...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA-sequencing of myxoinflammatory fibroblastic sarcomas reveals a novel SND1::BRAF fusion and 3 different molecular aberrations with the potential to upregulate the TEAD1 gene including SEC23IP::VGLL3 and TEAD1::MRTFB gene fusions.

Virchows Archiv : an international journal of pathology·2022
Same author

Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck.

Genes, chromosomes & cancer·2022
Same author

RREB1::MRTFB fusion-positive extra-glossal mesenchymal neoplasms: A series of five cases expanding their anatomic distribution and highlighting significant morphological and phenotypic diversity.

Genes, chromosomes & cancer·2022
Same author

Calcification in Salivary Gland Cancer Mimicking Sialolithiasis-A Diagnostic Pitfall on Imaging: Report of Two Cases and Brief Review of the Literature.

Journal of clinical medicine·2022
Same author

MDM2 is a useful diagnostic marker for nasopharyngeal carcinoma.

Pathology, research and practice·2022
Same author

Sinonasal mixed transitional epithelial-seromucinous papillary glandular neoplasms with BRAF p.V600E mutations - sinonasal analogues to the sialadenoma papilliferum family tumors.

Virchows Archiv : an international journal of pathology·2022

Related Experiment Video

Updated: Aug 15, 2025

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

5.9K

SWI/SNF-deficient Sinonasal Carcinomas.

Abbas Agaimy1

  • 1Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital, Erlangen, Germany.

Advances in Anatomic Pathology
|December 29, 2022
PubMed
Summary

Recent advances refine sinonasal carcinoma classification, identifying four subtypes linked to Switch/Sucrose nonfermentable (SWI/SNF) complex deficiencies. Immunohistochemistry aids diagnosis, reducing the need for genetic testing.

More Related Videos

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.7K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K

Related Experiment Videos

Last Updated: Aug 15, 2025

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

5.9K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.7K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K

Area of Science:

  • Pathology
  • Oncology
  • Genetics

Background:

  • The classification of poorly differentiated sinonasal carcinomas has evolved significantly over the past two decades.
  • Recent advancements favor molecular and etiological classifications over historical groupings like sinonasal undifferentiated carcinoma.
  • Defects in the Switch/Sucrose nonfermentable (SWI/SNF) chromatin remodeling complex are now recognized as key drivers of specific carcinoma subtypes.

Approach:

  • This review summarizes demographic, clinicopathological, and molecular features of newly defined sinonasal entities.
  • Focuses on four sinonasal carcinoma subtypes primarily driven by SWI/SNF complex deficiency.
  • Highlights the diagnostic utility of routine immunohistochemistry for detecting protein loss.

Key Points:

  • Four sinonasal entities are now defined by SWI/SNF complex deficiency: SMARCB1(INI1)-deficient sinonasal carcinoma, SMARCB1-deficient sinonasal adenocarcinoma, SMARCA4-deficient undifferentiated carcinoma, and a subset of sinonasal teratocarcinosarcoma.
  • Morphological and immunophenotypical distinctions are described for each subtype.
  • Loss of diagnostic proteins (SMARCB1, SMARCA4) is detectable via immunohistochemistry, making genetic testing generally unnecessary.

Conclusions:

  • The identification of SWI/SNF complex-deficient carcinomas represents a major advancement in sinonasal tumor classification.
  • Immunohistochemistry is a practical diagnostic tool for these subtypes.
  • This refined classification aids in understanding the molecular basis and clinical behavior of these rare malignancies.